← Back to patent-cliff list
CAS 1609259-55-3
4-(4,6-dimethylpyrimidin-5-yl)-3-methylphenol
Codes: PF-06412562-004
Application context (from source-drug indications)
精神分裂症谱系和其他精神病性疾病PF-06412562Parkinson's diseasePF-06412562SchizophreniaPF-06412562
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| PF-06412562 | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-(4-(4,6-dimethylpyrimidin-5-yl)-3-methylphenoxy)-1H-pyrazolo[4,3-c]pyridine→5-bromo-4,6-dimethylpyrimidine→2-(4-methoxy-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane→5-(4-methoxy-2-methylphenyl)-4,6-dimethylpyrimidine→4-(4,6-dimethylpyrimidin-5-yl)-3-methylphenol→4-chloro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[4,3-c]pyridine→4-(4-(4,6-dimethylpyrimidin-5-yl)-3-methylphenoxy)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[4,3-c]pyridine→4-chloro-1H-pyrazolo[4,3-c]pyridine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.